Medline Industries

Medline Industries, headquartered in the US and operating within the Medical, precision and optical instruments, watches and clocks sector, has established clear climate commitments and emissions reporting.

For the year 2025, Medline Industries reported a total of approximately 7.77 billion kg CO2e. This figure is composed of about 151.65 million kg CO2e for Scope 1 emissions, approximately 136.80 million kg CO2e for Scope 2 emissions, and a significant 7.48 billion kg CO2e for Scope 3 emissions. Key contributors to their Scope 3 footprint in 2025 included purchased goods and services (approximately 5.19 billion kg CO2e) and the end-of-life treatment of sold products (around 1.26 billion kg CO2e).

In 2024, the company's total emissions were approximately 5.09 billion kg CO2e. This comprised about 133.23 million kg CO2e in Scope 1 and approximately 141.26 million kg CO2e in Scope 2. Scope 3 emissions for 2024 amounted to approximately 4.81 billion kg CO2e, with purchased goods and services being the largest component at about 3.14 billion kg CO2e.

Medline Industries has set ambitious reduction targets. They aim for a 30% reduction in Scope 1 emissions from a 2023 baseline by 2030. Similarly, Scope 2 emissions are targeted for a 30% reduction by 2030 from the same 2023 baseline. The company also aims to achieve an absolute reduction of 42% for Scope 1 and Scope 2 emissions by 2030, from a 2022 baseline. Furthermore, Medline Industries projects an absolute reduction of 25% for Scope 3 emissions by 2030, also from a 2022 baseline. Their long-term ambition includes reaching Net Zero emissions by 2050. They have also stated an aim to reduce Scope 1 and Scope 2 emissions to near zero by the middle of this decade.

It is noted that Medline Industries' emissions data is cascaded from its parent organisation, Medline Industries, Inc., at cascade level 1, under a current subsidiary relationship.